Adrian Adams

Insider Reports History

Entity
Individual
Location
C/O Auxilium Pharmaceuticals, Inc., 640 Lee Road, Chesterbrook, PA
Signature
/s/ Martha Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adrian Adams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Director Common Stock 165K $208K $1.26 Jun 6, 2024 Direct
TALPHERA, INC. Director Common Stock 13.3K $14.7K $1.10 Jun 24, 2024 Direct
IMPEL PHARMACEUTICALS INC COB, CEO and President, Director Stock Option (right to buy) 200K Feb 14, 2023 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 45K Jun 6, 2024 Direct
TALPHERA, INC. Director Stock Option (Right to Buy) 13K Jun 24, 2024 Direct

Insider Reports Filed by Adrian Adams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLPH TALPHERA, INC. Jun 24, 2024 2 $0 4 Jun 24, 2024 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
ACRX ACELRX PHARMACEUTICALS INC Oct 10, 2023 2 $0 4 Dec 13, 2023 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Feb 14, 2023 1 $0 4 Feb 16, 2023 COB, CEO and President, Director
ACRX ACELRX PHARMACEUTICALS INC Jul 15, 2022 2 $0 4 Jul 15, 2022 Director
AKBA Akebia Therapeutics, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
IMPL IMPEL NEUROPHARMA INC Jan 26, 2022 1 $0 4 Jan 28, 2022 COB, CEO and President, Director
IMPL IMPEL NEUROPHARMA INC Aug 18, 2021 3 $280K 4 Aug 19, 2021 COB, CEO and President, Director
IMPL IMPEL NEUROPHARMA INC Jul 20, 2021 1 $0 4 Jul 26, 2021 COB, CEO and President, Director
ACRX ACELRX PHARMACEUTICALS INC Jun 17, 2021 2 $0 4 Jun 17, 2021 Director
AKBA Akebia Therapeutics, Inc. Jun 2, 2021 2 $0 4 Jun 3, 2021 Director